variability, these factors individually are unable to detect a patient's nutritional status. 12 As such, there is a move away from these biomarkers and a focus toward patient energy intake, anthropometric measurements (BMI, body composition, weight), and functional measures. 13, 14 The loss of SMM leads to objective weakness; is associated with functional impairment and disability, 15 a longer hospital stay, 16 higher economic burden, higher risk of nosocomial infections, 17 and decreased survival in both nonmalignant 15, 18 and malignant conditions [19] [20] [21] ; and predicts chemotherapy toxicity 22 and may be valuable in assessing patients prior to surgery. Although patients who lost more than 10% of their ideal body weight are at increased risk of postoperative complications, 23 weight loss alone poorly predicts outcome in head and neck cancer (HNC) patients when compared with depleted SMM. 24 Low SMM is an independent predictive factor for chemotherapy toxicity in patients with advanced HNC treated with primary chemoradiotherapy. 25 Grossberg et al 24 found that BMI and SMM depletion were powerful prognostic indicators of mortality. Nevertheless, BMI alone is not a reliable indicator of SMM. 26 Sarcopenia was initially defined as muscle mass 2 standard deviations below that of a healthy adult 2 ; there is now no clear definition of sarcopenia or 1 cutoff value for SMM that is valid for all oncological patients. 28 The use of functional imaging techniques such as dualenergy X-ray absorption (DEXA) and magnetic resonance imaging (MRI) has improved the measurement of SMM. Studies using computerized tomography (CT)/MRI of the psoas muscle cross-sectional area (CSA) at the level of the third lumbar (L3) vertebra 28, 29 have been used to estimate overall SMM. Assessing paravertebral muscle cross-sectional area (PVM CSA) on CT scan at the third cervical (C3) vertebra appears to be a good alternative to abdominal CT-scans, based on the strong correlation between skeletal muscle cross-sectional area at C3 and L3 vertebrae. 30 The C3 level is preferred as it captures only the neck muscles. Higher cervical images include the tongue muscles, while lower levels capture the trapezius muscle. The C3 level includes the following muscles: longus capitis, longus colli muscles located anterior to vertebrae and spinalis cervicis, semispinalis cervicis, semispinalis capitis, splenius capitis, and levator scapulae muscles.
There is currently little literature on the effect of sarcopenia on laryngeal cancer outcomes and no practical diagnostic tools for detecting sarcopenia. As laryngeal cancer staging includes cross-sectional imaging of the neck as routine and a skeletal muscle mass estimate using C3 level CT scans is practical and can be used to reliably to estimate SMM, this may be a cost-effective and widely available tool to preoperatively assess patients prone to postoperative complications among HNC patients. Abdominal CT scans that include the L3 and DEXA scans are not routinely performed in HNC patients.
As sarcopenia and low SMM are associated with increased postoperative wound complications in patients with HNC, 31 we investigated the relationship between PVM CSA at C3 using CT neck images and complications in advanced laryngeal cancer patients.
Methods
A single-center retrospective analysis of 77 laryngeal cancer patients who underwent total laryngectomy between January 1, 2010, and January 31, 2017, was performed. Data were collected from January 1, 2010, to March 31, 2017 . Patients with wide tumor resections including skin, extended pharyngeal resection requiring flap reconstruction (n = 3) and patients with positive surgical margins (n = 7) were excluded as these are risk factors for PCF 32, 33 ; patients with missing preoperative CT images (n = 7) were also excluded. Patients who had head and neck CT scans with a maximum interval of 2 months (n = 2) prior to total laryngectomy surgery were included (n = 60). All patients were discussed at a multidisciplinary tumor board. Total laryngectomy was preferred in cases where lung capacity was insufficient for partial surgery (FEV1 < 60%), >1 cm subglottic tumor extension, interaritenoid and postcricoid involvement, extralaryngeal extension, and vocal cord fixation due to cricoarytenoid joint invasion. The laryngectomies were performed with an open technique and simultaneous selective neck dissection (levels II-IV ± IV), prophylactic (n = 21) or therapeutic (n = 39). Informed consent was obtained from 52 patients, 5 patients died, and no contact information was available for 3. The institutional ethics committee approved the study.
Patient Demographics
Data including age, hospital stay time, BMI, smoking status, preoperative albumin levels, and co-existing morbidity (Charlson Comorbidity Index; CCI) scores 34 were collected as well as stage and prior treatment history including chemotherapy and radiation. The need of a pedicled or free flap for reconstruction was also included. Disease was staged per the American Joint Committee on Cancer using the TNM system. 35 Advanced-stage laryngeal squamous cell carcinoma (LSCC) was defined as T3-T4 and any TN+ or M+. Surgeryrelated wound complications (including infection, pharyngocutaneous fistula, dehiscence, hematoma, and seroma) defined as occurring within 30 postoperative days were recorded.
Cross-Sectional Measurement of Skeletal Muscle Index at C3
By calculating the CSA of neck muscles using staging CT images obtained preoperatively and the method devised by Swartz et al, 30 we estimated SMM. Swartz et al 30 recently presented a method to estimate SMM in routinely performed head and neck CT scans; CSA at C3 strongly correlated with L3 muscle CSA. The middle of the C3 vertebrae was chosen as the reference point on sagittal reformatted image, and CSA measurement was undertaken on the axial image at this level.
Skeletal muscle was quantified by the use of standard Hounsfield unit (HU) thresholds (−29 to 150). 36 Separately, the CSA of pixels that had a radiodensity between −29 and +150 HU was retrieved (further referred to as HU muscle area). Longus capitis, longus colli muscles, spinalis cervicis, semispinalis cervicis, semispinalis capitis, splenius capitis, and levator scapulae muscles were evaluated. The muscles were outlined using an image-processing system (PACS, Infinit Healthcare, South Korea, Guro-gu) by a single head and neck radiologist. The CSAs within the limits of the drawn boundaries were calculated using Xelis 3D software (V1.0.6.1, Infinit Healthcare, South Korea, Guro-gu) (Figure 1 ). The sum of the CSAs (mm 2 ) of all muscles was calculated for each patient; the total area was then normalized for patient height (CSA mm 
Exclusion of Sternocleidomastoid Muscles
Swartz et al 30 presented 2 methods to estimate SMM in routinely performed head and neck CT scans. They assessed the correlation between CSA at L3 and PVM only and between L3 and the PVM and only a single SCM muscle. Swartz et al 30 found significant correlation between the sum of the PVM and SCM muscles and L3 (r = 0.785, P < .001) and the PVM muscles only and L3 (r = 0.778, P < .001). However, as the former was "the stronger correlation," they only performed further analysis on the sum of the PVM and SCM muscles.
This approach had several limitations that they alluded to in their section subtitled "Clinically Missing Data." In their study, CSA assessment of 1 or both SCM muscles was impaired by lymph node metastases in 8 SCMs in 6 patients (7.6% of all HNC patient SCMs, 11.5% of all HNC patients, 17.6% of patients with neck metastases).
As such, we agreed with Scwartz et al 30 that CSA L3 correlated with CSA PVM alone but disagreed with them that the PVM and SCM method of measuring neck CSA was best for further analysis. Stronger correlation is not reason enough to ignore the fact that in a significant proportion of patients, data are not available, as the SCM muscles is invaded by lymph node metastases ( Figure 2 ).
To minimize measurement inconsistency for our study, we elected to use Schwartz et al's 30 first method that excluded the SCM muscles from the CSA calculations. Our study included 12 patients with N2c (bilateral) nodal involvement.
Statistical Analysis
A 1-way analysis of covariance (ANCOVA) was performed using SPSS statistical package for Mac version 23 (SPSS Inc, Chicago, Illinois, USA) to investigate if there was a difference in LMM in complication and no complication groups. Statistical significance was defined as P < .05. Covariates included were BMI, albumin, age, T-stage (categorized as 2, 3, or 4), and smoking status. Complication or no complication groups were defined as the independent variable. This allowed the creation of 95% confidence intervals (CI) for the LMM dependent variable. 
Results

Patient Demographics
Wound Complications
Wound complications occurred in 22 patients out of 60 (37%). One patient developed chyle leak; 1 had seroma, PCF, wound dehiscence, and hematoma together; 1 had hematoma and seroma together; 8 had PCF; 3 had seroma;
and 7 experienced dehiscence of their neck incision in the absence of a recognized salivary fistula ( Table 2 ). The PCFs occurred in 10 patients (16%); 6 (60%) were managed conservatively, and 4 required surgical closure with pectoralis major flap. Regarding wound dehiscence (n = 8), spontaneous closure with local wound care was noted in 6 (75%) patients, whereas a surgical closure was necessary in 2.
Cross-Sectional Skeletal Muscle Index and Postoperative Complications
Of the 60 patients, 22 were categorized in the complications group and 38 in the no complications group. ANCOVA identified a significant difference in PVM CSA between complication and no complication groups, F(1, 53 = 4.319, P = .043) ( Table 3 ). There were no significant differences in between-subject effects: T stage (F = 1.652, P = .204), BMI (F = 0.889, P = .35), albumin (F = 0.359, P = .552), age (F = 1.623, P = .208), and smoking (F = 4.319, P = .41). Estimated marginal means accounting for covariates are shown in Figure 3 . Covariates in the model are evaluated at the following values: T stage = 3.0167, BMI = 23.5787, albumin = 3.6492, age = 59.3667, and smoking = .50
Postoperative Complications Related to Other Variables
The focus of this study was the relationship between SMM, estimated by PVM CSA and postoperative complications. The relationship between postoperative complications and variables BMI and T-stage are widely known, and we did not concentrate on them in this study. However, we analyzed the data using t tests looking for differences between the complication and no complication groups in this study. Only BMI showed a significant difference between groups as an independent variable. This difference between groups is corrected for in the ANCOVA and not explored further.
Discussion
Postoperative wound complications account for most complications after major head and neck surgery. 38 Adequate nutritional status is necessary to support wound healing and surgical recovery. 39 Our study shows that lean muscle mass estimated by PVM CSA at C3 may be a potentially useful predictor of postoperative wound complications in laryngeal cancer patients. We found that PVM CSA level below 815 mm 2 /m 2 is a potential prognostic indicator of postoperative wound complication independent of other factors, such as BMI, hypoalbunemia, smoking history, and previous chemo/ radiotherapy. Grossberg et al 24 reported that patients with HNSCC and low SMM at presentation or after treatment exhibit decreased overall and cancer-specific survival. Weight loss itself poorly predicts outcome in HNC patients when compared with depleted SMM. Therefore, weight loss alone cannot be used reliably to stratify by risk patients with larynx cancer undergoing laryngectomy. In our study, we also did not find a statistically significant difference between the complication and no complication groups using PVM CSA with regards to T-or N-stages or low preoperative albumin.
Radiologically assessed muscle mass has been suggested previously as a surrogate marker of functional status. 37, 40 Published studies use criteria that are study specific, with some studies using imaging modalities such as CT or DEXA scans and others basing their criteria on muscle strength due to the cost-effectiveness of the measurements. [26] [27] [28] [29] 37 In the present study, image analysis was performed as described in a previous report. 16 For the purpose of comparing to literature values, measurements for skeletal muscle measured by CT were normalized to each patient's height. 41 Limitations of our study include retrospective data collection, lack of female patients, and sample size. Another limitation in our study in a few (n = 2) patients is that the interval between CT and laryngectomy was up to 2 months, and arguably there may have been significant weight loss in that time. The number of independent variables included in the ANCOVA was limited by the sample size and the number of wound complications and PCF. This may explain why we did not have a significant difference between complications and disease stage. A larger and more homogeneous patient cohort is warranted.
This study, to our knowledge, is the first to investigate the role of PVM CSA measured at the C3 vertebrate level and postoperative wound complication rate among larynx cancer patients. The lower boundary of the 95% CI no complication rate is 815 mm 2 /m 2 , and the upper boundary of the 95% for the complication group is 850 mm 2 /m 2 . We propose that a neck muscle index below 815 mm 2 /m 2 is considered as a risk factor for postoperative wound complications in head and neck patients that can be used as additional factor for stratifying low muscle mass and subsequent postoperative complication risk. We suggest this figure to research colleagues in head and neck surgery for future validation studies.
Conclusion
Paravertebral muscle cross-sectional area at the third vertebra level may help predict patients at high risk of postoperative wound complications before total laryngectomy and who would particularly benefit from preoperative optimization of nutritional status. The incorporation of CT-assessed muscle mass into routine presurgical assessment may aid nutritional status assessment.
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